Text Size

Pergolide Treatment for Substance Abusers - 4

This study has been completed.
Sponsor:
Collaborator:
New York State Psychiatric Institute
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00000269
First received: September 20, 1999
Last updated: August 16, 2005
Last verified: October 1995
History of Changes
  Purpose

The purpose of this study is to evaluate the safety and efficacy of pergolide for cocaine dependence.


Condition Intervention Phase
Cocaine-Related Disorders
Substance-Related Disorders
 Drug: Pergolide
 Phase 2

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Pergolide Treatment for Substance Abusers

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Side effects
  • Craving
  • Drug use
  • Improvement in functioning
  • Tolerability

Estimated Enrollment: 0
Study Start Date: October 1995
Estimated Study Completion Date: December 2001
  Eligibility

Ages Eligible for Study:   18 Years to 55 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Please contact site for information.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00000269

Locations
United States, New York
New York State Psychiatric Institute
New York, New York, United States, 10032
Sponsors and Collaborators
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute
Investigators
Principal Investigator: Herbert Kleber, M.D. New York State Psychiatric Institute
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00000269     History of Changes
Other Study ID Numbers: NIDA-09236-4, P50-09236-4
Study First Received: September 20, 1999
Last Updated: August 16, 2005
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cocaine-Related Disorders
Substance-Related Disorders
Mental Disorders
Pergolide
Dopamine Agonists
 Dopamine Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on June 18, 2013